| 6001 | Fracture of lower limb | injuries & poisonings | UKBB00000255 | 0.88 |
| 6002 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T401 | ECGA000401 | 0.88 |
| 6003 | PDLIM5 levels | GCST90470197 | 0.88 |
| 6004 | Diacylglycerol (18:0_18:1) levels | GCST90024714 | 0.88 |
| 6005 | Deviated nasal septum | FING00000409 | 0.88 |
| 6006 | NRCAM levels | GCST90470082 | 0.87 |
| 6007 | Principal component-derived dietary pattern 16 | GCST90133021 | 0.87 |
| 6008 | Bicarbonate (minimum, inv-norm transformed) | GCST90475150 | 0.87 |
| 6009 | Concentration of HDL particles | GCST90497414 | 0.87 |
| 6010 | Triglycerides to Total Lipids in Medium HDL percentage | GCST90498682 | 0.87 |
| 6011 | Type 1 diabetes | GCST90018705 | 0.87 |
| 6012 | Depression | Mental distress | UKBB00000165 | 0.87 |
| 6013 | wg rh intensity-contrast paracentral | GCST90003843 | 0.87 |
| 6014 | SCGN levels | GCST90470544 | 0.87 |
| 6015 | Monounsaturated fatty acids to total fatty acids percentage | GCST90499109 | 0.87 |
| 6016 | Prescriptions - sulfonylurea|diabetes | UKBB00000703 | 0.87 |
| 6017 | Reticulocyte count | GCST004622 | 0.87 |
| 6018 | EPHA4 levels | GCST90469131 | 0.87 |
| 6019 | Other mental disorder | mental disorders | UKBB00000614 | 0.87 |
| 6020 | LTB4R levels | GCST90422164 | 0.87 |
| 6021 | Heart attack | GCST90468132 | 0.87 |
| 6022 | LTA levels | GCST90469813 | 0.87 |
| 6023 | ICD10 D25: Leiomyoma of uterus | GCST90454204 | 0.86 |
| 6024 | DBI/EDAR ratio | GCST90314408 | 0.86 |
| 6025 | ITGB1 levels | GCST90469643 | 0.86 |
| 6026 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122) | GCST90320941 | 0.86 |
| 6027 | Triglycerides to Total Lipids in Medium VLDL percentage | GCST90499073 | 0.86 |
| 6028 | ALCAM/NOTCH1 ratio | GCST90313241 | 0.86 |
| 6029 | Iron deficiency anaemia | FING00000699 | 0.86 |
| 6030 | Volume of left whole amygdala | GCST90474986 | 0.86 |
| 6031 | FABP2/LGALS4 ratio | GCST90314756 | 0.86 |
| 6032 | Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448) | GCST90132967 | 0.86 |
| 6033 | EFNA4 levels | GCST90469081 | 0.86 |
| 6034 | IDP dMRI TBSS L3 Uncinate fasciculus R | GCST90004215 | 0.86 |
| 6035 | Histidine levels | GCST90092830 | 0.86 |
| 6036 | rfMRI connectivity (ICA25 edge 101) | GCST90004744 | 0.86 |
| 6037 | Skin red/green component | GCST90320258 | 0.85 |
| 6038 | RHOC/TBCC ratio | GCST90315775 | 0.85 |
| 6039 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T422 | ECGU000422 | 0.85 |
| 6040 | aseg rh volume Lateral-Ventricle | GCST90002633 | 0.85 |
| 6041 | GLA levels | GCST90469354 | 0.85 |
| 6042 | HYOU1/PTPRF ratio | GCST90315102 | 0.85 |
| 6043 | MSRA/P4HB ratio | GCST90315495 | 0.85 |
| 6044 | Phospholipids in IDL | GCST90497626 | 0.85 |
| 6045 | rfMRI connectivity (ICA100 edge 614) | GCST90005467 | 0.85 |
| 6046 | PMVK levels | GCST90470272 | 0.85 |
| 6047 | Free cholesterol to total lipids ratio in small HDL | GCST90092949 | 0.85 |
| 6048 | EBAG9/MITD1 ratio | GCST90314566 | 0.85 |
| 6049 | Alzheimer's disease or family history of Alzheimer's disease | GCST90012877 | 0.85 |
| 6050 | Physical activity (Relative amplitude) | GCST90061432 | 0.84 |
| 6051 | Saturated fatty acids levels | GCST90502670 | 0.84 |
| 6052 | PTPRH levels | GCST90470382 | 0.84 |
| 6053 | Prescriptions - thiazide diuretic|diuretic | UKBB00000704 | 0.84 |
| 6054 | BLVRB/CA1 ratio | GCST90313521 | 0.84 |
| 6055 | aseg rh volume Hippocampus | GCST90002641 | 0.84 |
| 6056 | LTA4H levels | GCST90469812 | 0.84 |
| 6057 | Cholesteryl esters to total lipids in small VLDL percentage (UKB data field 23601) | GCST90269698 | 0.84 |
| 6058 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T377 | ECGU000377 | 0.84 |
| 6059 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T500 | ECGA000500 | 0.84 |
| 6060 | Deaf mutism, not elsewhere classified | FING00000378 | 0.84 |
| 6061 | Emotional neglect | GCST90551846 | 0.84 |
| 6062 | Cholesteryl esters to total lipids ratio in small LDL | GCST90092959 | 0.84 |
| 6063 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T482 | ECGU000482 | 0.84 |
| 6064 | Hypertrophy of breast in women and men | FING00000645 | 0.84 |
| 6065 | CGREF1/FAM3C ratio | GCST90314032 | 0.83 |
| 6066 | KLKB1 levels | GCST90469708 | 0.83 |
| 6067 | TANK levels | GCST90470803 | 0.83 |
| 6068 | DSG3/FABP9 ratio | GCST90314559 | 0.83 |
| 6069 | Spleen iron concentration | GCST90101831 | 0.83 |
| 6070 | LAT/PLXNA4 ratio | GCST90315286 | 0.83 |
| 6071 | Free cholesterol levels in very small VLDL | GCST90093032 | 0.83 |
| 6072 | Gestational diabetes (for exclusion) | FING00000573 | 0.83 |
| 6073 | N-delta-acetylornithine levels | GCST90200691 | 0.83 |
| 6074 | CLIP2/LAT2 ratio | GCST90314128 | 0.83 |
| 6075 | FST/FSTL3 ratio | GCST90314882 | 0.83 |
| 6076 | Stenosis and insufficiency of lacrimal passages | FING00001334 | 0.83 |
| 6077 | SMPD1 levels | GCST90470684 | 0.83 |
| 6078 | SERPINI2 levels | GCST90470603 | 0.83 |
| 6079 | Degree of unsaturation | GCST90502753 | 0.83 |
| 6080 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12 | ECGA000012 | 0.83 |
| 6081 | Total lipids in very small VLDL | GCST90500813 | 0.83 |
| 6082 | AXIN1/IKBKG ratio | GCST90313409 | 0.83 |
| 6083 | Phospholipids in IDL (UKB data field 23525) | GCST90269622 | 0.83 |
| 6084 | Cholesterol levels in large VLDL | GCST90092868 | 0.82 |
| 6085 | Phospholipids in large HDL | GCST90497847 | 0.82 |
| 6086 | aparc-a2009s rh area G-postcentral | GCST90003398 | 0.82 |
| 6087 | Concentration of very small VLDL particles | GCST90500826 | 0.82 |
| 6088 | Basophil percentage of white cells | GCST004631 | 0.82 |
| 6089 | IL1R1 levels | GCST90469571 | 0.82 |
| 6090 | GDI2 levels | GCST90088004 | 0.82 |
| 6091 | Systolic blood pressure | GCST90472780 | 0.82 |
| 6092 | DNAJA2/HPCAL1 ratio | GCST90314503 | 0.82 |
| 6093 | Nontoxic nodular goiter | endocrine/metabolic | UKBB00000529 | 0.82 |
| 6094 | LAMA4/NID1 ratio | GCST90315272 | 0.82 |
| 6095 | X-11787 levels | GCST90200465 | 0.82 |
| 6096 | DTI TBSS MD Posterior corona radiata R | GCST90384598 | 0.82 |
| 6097 | Thick vs thin eyebrows | GCST006093 | 0.82 |
| 6098 | BLVRB/CA2 ratio | GCST90313522 | 0.82 |
| 6099 | Creatinine levels | GCST90132719 | 0.82 |
| 6100 | Cholesterol to total lipids ratio in large HDL | GCST90092845 | 0.82 |
| 6101 | Own or rent accommodation lived in - Own outright (by you or someone in your household) | Household | UKBB00000623 | 0.81 |
| 6102 | AXIN1/ITGB1BP2 ratio | GCST90313412 | 0.81 |
| 6103 | Phospholipids to total lipids in medium HDL percentage (UKB data field 23639) | GCST90269736 | 0.81 |
| 6104 | Polyunsaturated fatty acid levels | GCST90502134 | 0.81 |
| 6105 | Free cholesterol in medium LDL | GCST90498774 | 0.81 |
| 6106 | Activities undertaken to treat depression | Depression | UKBB00000010 | 0.81 |
| 6107 | RAD23B levels | GCST90470418 | 0.81 |
| 6108 | Gonarthrosis [arthrosis of knee] | Arthrosis | UKBB00000290 | 0.81 |
| 6109 | PIKFYVE levels | GCST90470235 | 0.81 |
| 6110 | F-fatty/salty food liking (derived food-liking factor) | GCST90094759 | 0.81 |
| 6111 | IRAK1 levels | GCST90469627 | 0.81 |
| 6112 | Average diameter for HDL particles | GCST90132702 | 0.81 |
| 6113 | Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144) | GCST90132931 | 0.81 |
| 6114 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90092943 | 0.81 |
| 6115 | Total lipids in medium VLDL (UKB data field 23503) | GCST90269600 | 0.81 |
| 6116 | Total cholesterol minus HDL-C levels | GCST90092930 | 0.80 |
| 6117 | Bifidobacterium catenulatum abundance in stool | GCST90032224 | 0.80 |
| 6118 | DCXR/GSTA1 ratio | GCST90314437 | 0.80 |
| 6119 | CKAP4/LTBR ratio | GCST90314074 | 0.80 |
| 6120 | Basophil count | GCST90018726 | 0.80 |
| 6121 | FABP9 levels | GCST90469179 | 0.80 |
| 6122 | EPHA2 levels | GCST90469130 | 0.80 |
| 6123 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14 | ECGA000014 | 0.80 |
| 6124 | Left-hemisphere control network to hippocampus white-matter structural connectivity | GCST90302756 | 0.80 |
| 6125 | Female infertility | FING00000536 | 0.80 |
| 6126 | CD58/ERBB3 ratio | GCST90313848 | 0.80 |
| 6127 | Thyroid stimulating hormone levels | GCST90296333 | 0.80 |
| 6128 | PSG1 levels | GCST90470353 | 0.80 |
| 6129 | Left-hemisphere default mode network to thalamus white-matter structural connectivity | GCST90302767 | 0.80 |
| 6130 | SOST/SPP1 ratio | GCST90315871 | 0.80 |
| 6131 | T1 FIRST volume L Hipp | GCST90383990 | 0.80 |
| 6132 | ERBIN/SIRT2 ratio | GCST90314696 | 0.79 |
| 6133 | IDP dMRI ProbtrackX ISOVF slf r | GCST90004547 | 0.79 |
| 6134 | Basophil percentage of white cells variance | GCST90565688 | 0.79 |
| 6135 | CRTAM/PDCD1 ratio | GCST90314279 | 0.79 |
| 6136 | OSCAR levels | GCST90470131 | 0.79 |
| 6137 | BCAN/DPP6 ratio | GCST90313478 | 0.79 |
| 6138 | Cholesteryl esters in large VLDL (UKB data field 23499) | GCST90269596 | 0.79 |
| 6139 | CA2/CA3 ratio | GCST90313576 | 0.79 |
| 6140 | LACRT levels | GCST90469725 | 0.79 |
| 6141 | CASP8/SEPTIN9 ratio | GCST90313658 | 0.79 |
| 6142 | EIF4G1/MAVS ratio | GCST90314636 | 0.79 |
| 6143 | Cholesteryl ester levels in medium LDL | GCST90092906 | 0.79 |
| 6144 | Heart valve replaced (PheCode 395.6) | GCST90475915 | 0.79 |
| 6145 | FOLR2/HAVCR2 ratio | GCST90314865 | 0.79 |
| 6146 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90500949 | 0.79 |
| 6147 | Age-related macular degeneration | GCST90086111 | 0.79 |
| 6148 | aparc-pial rh area parsopercularis | GCST90003191 | 0.79 |
| 6149 | PDGFRB levels | GCST90470192 | 0.79 |
| 6150 | DUSP3 levels | GCST90469053 | 0.79 |
| 6151 | DAPP1/PTPN6 ratio | GCST90314397 | 0.79 |
| 6152 | Polycystic ovarian syndrome, consortium definition | FING00001184 | 0.79 |
| 6153 | HAVCR1 levels | GCST90469431 | 0.78 |
| 6154 | CDC37 levels | GCST90468665 | 0.78 |
| 6155 | Chronic Kidney Disease, Stage IV (PheCode 585.34) | GCST90476130 | 0.78 |
| 6156 | Linoleic acid to total fatty acids percentage | GCST90502025 | 0.78 |
| 6157 | Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093043 | 0.78 |
| 6158 | SLC51B levels | GCST90470664 | 0.78 |
| 6159 | MANF/TXNDC5 ratio | GCST90315370 | 0.78 |
| 6160 | Phospholipid levels in small HDL | GCST90092952 | 0.78 |
| 6161 | AKR1B1 levels | GCST90468273 | 0.78 |
| 6162 | Concentration of small HDL particles | GCST90499461 | 0.78 |
| 6163 | Free cholesterol in VLDL (UKB data field 23420) | GCST90269517 | 0.78 |
| 6164 | Cholesteryl esters in very small VLDL (UKB data field 23520) | GCST90269617 | 0.78 |
| 6165 | DTI TBSS L3 Anterior corona radiata L | GCST90384547 | 0.78 |
| 6166 | Phospholipids to Total Lipids in Medium LDL percentage | GCST90498852 | 0.77 |
| 6167 | BA-exvivo rh area BA1 | GCST90003221 | 0.77 |
| 6168 | DTI TBSS MD Superior corona radiata L | GCST90384597 | 0.77 |
| 6169 | Principal component-derived dietary pattern 28 | GCST90133033 | 0.77 |
| 6170 | PTPN1 levels | GCST90470376 | 0.77 |
| 6171 | CLEC6A levels | GCST90468777 | 0.77 |
| 6172 | REN levels | GCST90470454 | 0.77 |
| 6173 | PMM2 levels | GCST90470270 | 0.77 |
| 6174 | IDP T1 FAST ROIs L pallidum | GCST90002553 | 0.77 |
| 6175 | Osteopathies and chondropathies | FING00000913 | 0.77 |
| 6176 | HNRNPK/USP8 ratio | GCST90315070 | 0.77 |
| 6177 | Treatment/medication code - atenolol | Medications | UKBB00000842 | 0.77 |
| 6178 | REST UKBBICA NODEamps25 0005 | GCST90385488 | 0.77 |
| 6179 | LCN2/RETN ratio | GCST90315308 | 0.77 |
| 6180 | AMOTL2 levels | GCST90468294 | 0.77 |
| 6181 | Concentration of large VLDL particles | GCST90498226 | 0.77 |
| 6182 | Dermatophytosis (PheCode 110.1) | GCST90475561 | 0.77 |
| 6183 | Reason for reducing amount of alcohol drunk - Health precaution | Alcohol | UKBB00000734 | 0.77 |
| 6184 | MESD/NCK2 ratio | GCST90315421 | 0.77 |
| 6185 | Phosphatidylcholine (14:0_22:6) levels | GCST90024234 | 0.77 |
| 6186 | FAM3B/GPA33 ratio | GCST90314778 | 0.77 |
| 6187 | Ceramide_40:1_[M-H]1- levels | GCST90060198 | 0.76 |
| 6188 | Linoleic acid levels | GCST90502010 | 0.76 |
| 6189 | SPOCK2 levels | GCST90242987 | 0.76 |
| 6190 | COMP/MYOC ratio | GCST90314191 | 0.76 |
| 6191 | aparc-a2009s rh area G-pariet-inf-Angular | GCST90003395 | 0.76 |
| 6192 | OPTC levels | GCST90470128 | 0.76 |
| 6193 | Triglycerides in HDL | GCST90497467 | 0.76 |
| 6194 | COL18A1/RARRES2 ratio | GCST90314169 | 0.76 |
| 6195 | AZU1/MPO ratio | GCST90313425 | 0.76 |
| 6196 | DTI TBSS L3 Superior corona radiata L | GCST90384549 | 0.76 |
| 6197 | DTI TBSS L3 Fornix cres+Stria terminalis L | GCST90384563 | 0.76 |
| 6198 | Total lipids in large VLDL | GCST90498207 | 0.76 |
| 6199 | GBP6 levels | GCST90241368 | 0.76 |
| 6200 | Female infertility, associated with anovulation | FING00000537 | 0.76 |
| 6201 | IDP dMRI ProbtrackX ICVF cgh r | GCST90004382 | 0.76 |
| 6202 | LAT/LYN ratio | GCST90315283 | 0.76 |
| 6203 | SPINT1/SUSD2 ratio | GCST90315878 | 0.76 |
| 6204 | ADH4/KYNU ratio | GCST90313193 | 0.75 |
| 6205 | Number of operations, self-reported | Operations | UKBB00000539 | 0.75 |
| 6206 | RHOC levels | GCST90470467 | 0.75 |
| 6207 | FLT4/KDR ratio | GCST90314861 | 0.75 |
| 6208 | aparc-pial rh area superiorparietal | GCST90003202 | 0.75 |
| 6209 | Other and unspecified iron deficiency | FING00000940 | 0.75 |
| 6210 | Free testosterone levels | GCST90239826 | 0.75 |
| 6211 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119) | GCST90320682 | 0.75 |
| 6212 | Total phospholipids in lipoprotein particles (UKB data field 23411) | GCST90269508 | 0.75 |
| 6213 | IGSF9 levels | GCST90469541 | 0.75 |
| 6214 | IDP dMRI TBSS FA Retrolenticular part of internal capsule L | GCST90003898 | 0.75 |
| 6215 | Volume of left accessory basal nucleus | GCST90474940 | 0.75 |
| 6216 | IDP T1 FAST ROIs R putamen | GCST90002552 | 0.75 |
| 6217 | BIRC2 levels | GCST90468446 | 0.75 |
| 6218 | Lipoma of skin and subcutaneous tissue (PheCode 214.1) | GCST90475619 | 0.75 |
| 6219 | Spread type: Any oil based spread vs never use spread (UKB data field 1428) | GCST90132949 | 0.75 |
| 6220 | REST UKBBICA NODEamps25 0007 | GCST90385490 | 0.75 |
| 6221 | Total lipid levels in large LDL | GCST90092862 | 0.75 |
| 6222 | Coronary artery disease (confirmatory factor analysis Factor 16) | GCST90309350 | 0.75 |
| 6223 | Reason for reducing amount of alcohol drunk - Other reason | Alcohol | UKBB00000735 | 0.75 |
| 6224 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T182 | ECGA000182 | 0.74 |
| 6225 | Polyunsaturated fatty acids levels (UKB data field 23446) | GCST90269543 | 0.74 |
| 6226 | ICAM5 levels | GCST90469502 | 0.74 |
| 6227 | TGFBR3 levels | GCST90470848 | 0.74 |
| 6228 | Triglycerides to total lipids ratio in very large HDL | GCST90093015 | 0.74 |
| 6229 | SFTPA2/SFTPD ratio | GCST90315839 | 0.74 |
| 6230 | Cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23580) | GCST90269677 | 0.74 |
| 6231 | Blood cell traits latent factor 20 (red cell) | GCST90559262 | 0.74 |
| 6232 | Spondylosis and allied disorders (PheCode 721) | GCST90476235 | 0.74 |
| 6233 | VSIG4 levels | GCST90471052 | 0.74 |
| 6234 | ROBO2/SFTPD ratio | GCST90315785 | 0.74 |
| 6235 | Cholesteryl Esters to Total Lipids in Medium HDL percentage | GCST90498550 | 0.74 |
| 6236 | DTI autoptx FA fmi tract | GCST90385123 | 0.74 |
| 6237 | Cholesterol | Blood biochemistry | UKBB00000134 | 0.74 |
| 6238 | MCAM/NTRK3 ratio | GCST90315409 | 0.74 |
| 6239 | TNFSF11 levels | GCST90470918 | 0.74 |
| 6240 | Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9) | GCST90475908 | 0.74 |
| 6241 | Hip fracture | GCST90161240 | 0.74 |
| 6242 | APOC1 levels | GCST90468336 | 0.74 |
| 6243 | Cholesterol in medium HDL (UKB data field 23568) | GCST90269665 | 0.74 |
| 6244 | Age when finished full-time education (weighted GWA) | GCST90267281 | 0.74 |
| 6245 | CLEC1B/EGF ratio | GCST90314089 | 0.73 |
| 6246 | DARS1/USP8 ratio | GCST90314407 | 0.73 |
| 6247 | Anaphylactic shock due to adverse effect of correct drug or medication properly administered | FING00000084 | 0.73 |
| 6248 | Psoas tendinitis | FING00001221 | 0.73 |
| 6249 | Cholesteryl ester levels in small LDL | GCST90092958 | 0.73 |
| 6250 | Blood cell traits latent factor 13 (red cell) | GCST90559255 | 0.73 |
| 6251 | Cholesterol in Large LDL | GCST90497919 | 0.73 |
| 6252 | DBN1 levels | GCST90468950 | 0.73 |
| 6253 | ITIH4 levels | GCST90469651 | 0.73 |
| 6254 | aseg lh volume CerebralWhiteMatter | GCST90002615 | 0.73 |
| 6255 | Total cholesterol levels (UKB data field 23400) | GCST90269497 | 0.73 |
| 6256 | aparc-a2009s rh area G-occipital-sup | GCST90003390 | 0.73 |
| 6257 | SRPX levels | GCST90470744 | 0.73 |
| 6258 | MYL3 levels | GCST90469977 | 0.73 |
| 6259 | aparc-DKTatlas rh area precentral | GCST90003287 | 0.73 |
| 6260 | Total cholesterol response to statins (relative logarithmic difference) | GCST90455608 | 0.73 |
| 6261 | TARBP2/TDRKH ratio | GCST90315902 | 0.73 |
| 6262 | Omega-3 fatty acid levels | GCST90502062 | 0.73 |
| 6263 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T227 | ECGU000227 | 0.72 |
| 6264 | TNR levels | GCST90470929 | 0.72 |
| 6265 | AXL/IL18BP ratio | GCST90313420 | 0.72 |
| 6266 | Mean corpuscular hemoglobin | GCST90018744 | 0.72 |
| 6267 | Docosahexaenoic acid to total fatty acids percentage | GCST90501991 | 0.72 |
| 6268 | Gamma-CEHC glucuronide levels | GCST90199941 | 0.72 |
| 6269 | KLK13 levels | GCST90469699 | 0.72 |
| 6270 | HippSubfield lh volume Whole-hippocampus | GCST90002689 | 0.72 |
| 6271 | DLL1/EFEMP1 ratio | GCST90314494 | 0.72 |
| 6272 | PLA2G1B levels | GCST90470246 | 0.72 |
| 6273 | Cholesteryl esters in medium HDL (UKB data field 23569) | GCST90269666 | 0.72 |
| 6274 | Psoriasis vulgaris | GCST90018687 | 0.72 |
| 6275 | Miserableness | Mental health | UKBB00000478 | 0.72 |
| 6276 | TNFAIP2 levels | GCST90470896 | 0.72 |
| 6277 | Free cholesterol levels in small VLDL | GCST90092972 | 0.72 |
| 6278 | Disorders of orbit | FING00000449 | 0.72 |
| 6279 | SH2B3/SUGT1 ratio | GCST90315840 | 0.72 |
| 6280 | C-reactive protein | Blood biochemistry | UKBB00000113 | 0.72 |
| 6281 | CDCP1/MSR1 ratio | GCST90313938 | 0.72 |
| 6282 | CD5 levels | GCST90468641 | 0.72 |
| 6283 | Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressure | UKBB00000376 | 0.72 |
| 6284 | Transient global amnesia | FING00001374 | 0.71 |
| 6285 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T421 | ECGU000421 | 0.71 |
| 6286 | Cholesteryl ester levels in very large VLDL | GCST90093018 | 0.71 |
| 6287 | Triglyceride levels in large LDL | GCST90092866 | 0.71 |
| 6288 | Hypertrophy of breast | FING00000644 | 0.71 |
| 6289 | GSR levels | GCST90469410 | 0.71 |
| 6290 | CD300C/HAVCR2 ratio | GCST90313789 | 0.71 |
| 6291 | RARRES2/TFPI ratio | GCST90315760 | 0.71 |
| 6292 | HEPH levels | GCST90469446 | 0.71 |
| 6293 | Treatment/medication code - aspirin | Medications | UKBB00000841 | 0.71 |
| 6294 | ITM2A levels | GCST90469653 | 0.71 |
| 6295 | HYAL1 levels | GCST90469495 | 0.70 |
| 6296 | CD69/CDKN2D ratio | GCST90313866 | 0.70 |
| 6297 | Methods of admission to hospital (recoded) - Emergency admission: A&E | Summary Administration | UKBB00000464 | 0.70 |
| 6298 | Total free cholesterol levels (UKB data field 23419) | GCST90269516 | 0.70 |
| 6299 | IDP T1 FAST ROIs R caudate | GCST90002550 | 0.70 |
| 6300 | WFDC12 levels | GCST90471073 | 0.70 |
| 6301 | Frailty (Factor 3 - Multimorbidity) | GCST90624049 | 0.70 |
| 6302 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 32) | GCST90320595 | 0.70 |
| 6303 | C5 levels | GCST90468500 | 0.70 |
| 6304 | EDAR/TNFSF12 ratio | GCST90314591 | 0.70 |
| 6305 | BCAN/KLK6 ratio | GCST90313479 | 0.70 |
| 6306 | FGF5 levels | GCST90469226 | 0.70 |
| 6307 | NADK/S100A11 ratio | GCST90315513 | 0.70 |
| 6308 | ANGPT1/CPXM1 ratio | GCST90313262 | 0.70 |
| 6309 | Inguinal hernia | GCST90018648 | 0.69 |
| 6310 | CTHRC1 levels | GCST90468902 | 0.69 |
| 6311 | LDLRAP1 levels | GCST90469749 | 0.69 |
| 6312 | Occlusion and stenosis of precerebral arteries (PheCode 433.1) | GCST90475986 | 0.69 |
| 6313 | Omega-3 fatty acid levels | GCST90502425 | 0.69 |
| 6314 | Normotensive glaucoma | FING00000892 | 0.69 |
| 6315 | Ceramide (d18:2/24:1) levels | GCST90024684 | 0.69 |
| 6316 | Total esterified cholesterol levels | GCST90500036 | 0.69 |
| 6317 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13 | ECGA000013 | 0.69 |
| 6318 | Cholesterol in Small HDL | GCST90499348 | 0.69 |
| 6319 | ALOX15B levels | GCST90617547 | 0.69 |
| 6320 | SLC27A4 levels | GCST90470657 | 0.69 |
| 6321 | LDL direct | Blood biochemistry | UKBB00000386 | 0.69 |
| 6322 | CDKN1A levels | GCST90468684 | 0.69 |
| 6323 | F-healthy food liking (derived food-liking factor) | GCST90094779 | 0.69 |
| 6324 | Mean platelet volume at delivery | GCST90302232 | 0.69 |
| 6325 | EDAR/SNAP23 ratio | GCST90314587 | 0.69 |
| 6326 | Presence of cardiac and vascular implants and grafts | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000708 | 0.69 |
| 6327 | aparc-DKTatlas rh area caudalmiddlefrontal | GCST90003267 | 0.68 |
| 6328 | CD244/TREML2 ratio | GCST90313767 | 0.68 |
| 6329 | Fruit intake (standard GWA) | GCST90267282 | 0.68 |
| 6330 | Total esterified cholesterol levels (UKB data field 23415) | GCST90269512 | 0.68 |
| 6331 | Systolic blood pressure, manual reading | Blood pressure | UKBB00000810 | 0.68 |
| 6332 | wg lh intensity-contrast transversetemporal | GCST90003825 | 0.68 |
| 6333 | Clonal haematopoiesis of indeterminate potential (DNMT3A mutation) | GCST90165271 | 0.68 |
| 6334 | ATRAID levels | GCST90468399 | 0.68 |
| 6335 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79) | GCST90320898 | 0.68 |
| 6336 | Cholesteryl esters to total lipids ratio in medium HDL | GCST90092895 | 0.68 |
| 6337 | Chronic pancreatitis | GCST90018601 | 0.68 |
| 6338 | Baked/steamed fish liking | GCST90094696 | 0.68 |
| 6339 | DAG1/F2R ratio | GCST90314374 | 0.68 |
| 6340 | Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4) | GCST90476243 | 0.68 |
| 6341 | HSDL2 levels | GCST90469485 | 0.68 |
| 6342 | LYPD3 levels | GCST90469828 | 0.68 |
| 6343 | Total lipids in IDL (UKB data field 23524) | GCST90269621 | 0.68 |
| 6344 | Body fat rate | GCST90278619 | 0.68 |
| 6345 | SEPHS1 levels | GCST90242740 | 0.68 |
| 6346 | Alzheimer's disease or family history of Alzheimer's disease | GCST007320 | 0.68 |
| 6347 | MAP3K5 levels | GCST90469854 | 0.68 |
| 6348 | FHIT/GLOD4 ratio | GCST90314817 | 0.68 |
| 6349 | Phosphoglycerides levels (UKB data field 23434) | GCST90269531 | 0.68 |
| 6350 | SERPINH1 levels | GCST90470601 | 0.68 |
| 6351 | DAB2/FKBP1B ratio | GCST90314362 | 0.68 |
| 6352 | CD276 levels | GCST90468614 | 0.67 |
| 6353 | RBKS levels | GCST90470433 | 0.67 |
| 6354 | Substance dependence | GCST90018704 | 0.67 |
| 6355 | IDP dMRI TBSS ISOVF Cingulum cingulate gyrus R | GCST90004511 | 0.67 |
| 6356 | CPA1/CPB1 ratio | GCST90314202 | 0.67 |
| 6357 | Waking up during the night and not easily going back to sleep | GCST90476386 | 0.67 |
| 6358 | Modified Stumvoll Insulin Sensitivity Index | GCST90267574 | 0.67 |
| 6359 | Graves' disease (PheCode 242.1) | GCST90475644 | 0.67 |
| 6360 | RBPMS2 levels | GCST90470441 | 0.67 |
| 6361 | Mid-point of the five least active hours of the day | GCST90061434 | 0.67 |
| 6362 | Plasma X-24544 levels in chronic kidney disease | GCST90266757 | 0.67 |
| 6363 | Chained arithmetic | Fluid intelligence / reasoning | UKBB00000126 | 0.67 |
| 6364 | PSMD9/UBAC1 ratio | GCST90315735 | 0.67 |
| 6365 | P4HB levels | GCST90470140 | 0.67 |
| 6366 | Beta-hydroxyisovaleroylcarnitine levels | GCST90199802 | 0.67 |
| 6367 | Free cholesterol in large HDL | GCST90497780 | 0.67 |
| 6368 | APOA1 levels | GCST90269537 | 0.67 |
| 6369 | Omega-6 fatty acid levels | GCST90502095 | 0.67 |
| 6370 | Concentration of very large HDL particles | GCST90500431 | 0.67 |
| 6371 | PDGFB/VEGFC ratio | GCST90315635 | 0.67 |
| 6372 | Cholesterol to total lipids in small LDL percentage (UKB data field 23625) | GCST90269722 | 0.67 |
| 6373 | Cholesterol to Total Lipids in Large VLDL percentage | GCST90498130 | 0.67 |
| 6374 | IDUA levels | GCST90469508 | 0.66 |
| 6375 | Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivity | GCST90302674 | 0.66 |
| 6376 | PCDH7 levels | GCST90470171 | 0.66 |
| 6377 | COCH levels | GCST90468810 | 0.66 |
| 6378 | Concentration of small LDL particles | GCST90092963 | 0.66 |
| 6379 | Total cholines levels (UKB data field 23436) | GCST90269533 | 0.66 |
| 6380 | eGFR in diabetes mellitus (loose) (minimal adjustment) | GCST90624783 | 0.66 |
| 6381 | aparc-Desikan lh thickness paracentral | GCST90003461 | 0.66 |
| 6382 | ThalamNuclei lh volume L-Sg | GCST90002716 | 0.66 |
| 6383 | Left-hemisphere limbic network to thalamus white-matter structural connectivity | GCST90302736 | 0.66 |
| 6384 | Prevotella sp000434975 abundance in stool | GCST90032518 | 0.66 |
| 6385 | ThalamNuclei lh volume PuI | GCST90002714 | 0.66 |
| 6386 | CASP2 levels | GCST90468544 | 0.66 |
| 6387 | CLEC1B/HBEGF ratio | GCST90314092 | 0.65 |
| 6388 | LSIL lesion of the cervix uteri, vagina or vulva | FING00000733 | 0.65 |
| 6389 | IDP T1 FAST ROIs R lingual gyrus | GCST90002522 | 0.65 |
| 6390 | GALNT5 levels | GCST90469298 | 0.65 |
| 6391 | CBLN4/RET ratio | GCST90313660 | 0.65 |
| 6392 | EFNA4/TNFRSF10B ratio | GCST90314605 | 0.65 |
| 6393 | PPP1R12A levels | GCST90470300 | 0.65 |
| 6394 | B4GALT1/SPON2 ratio | GCST90313434 | 0.65 |
| 6395 | Hematocrit | GCST90278634 | 0.65 |
| 6396 | Umbilical hernia | FING00001395 | 0.65 |
| 6397 | GAPDH levels | GCST90469302 | 0.65 |
| 6398 | Medication use (drugs used in diabetes) | GCST90018761 | 0.65 |
| 6399 | GPC1 levels | GCST90469386 | 0.65 |
| 6400 | Malignant neoplasm of bladder (PheCode 189.21) | GCST90475599 | 0.65 |
| 6401 | ATXN10/SLC27A4 ratio | GCST90313399 | 0.65 |
| 6402 | aparc-Desikan lh volume parstriangularis | GCST90002787 | 0.64 |
| 6403 | Cholesteryl esters to total lipids ratio in small VLDL | GCST90092971 | 0.64 |
| 6404 | XPNPEP2 levels | GCST90471084 | 0.64 |
| 6405 | Gout | FING00000587 | 0.64 |
| 6406 | CD3 on Terminally Differentiated CD4+ T cell | GCST90001844 | 0.64 |
| 6407 | LBR/POLR2F ratio | GCST90315297 | 0.64 |
| 6408 | ADAMTSL2 levels | GCST90468228 | 0.64 |
| 6409 | RGCC levels | GCST90470461 | 0.64 |
| 6410 | Cholesterol to total lipids ratio in small LDL | GCST90092957 | 0.64 |
| 6411 | USP8 levels | GCST90471022 | 0.64 |
| 6412 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | GCST90475350 | 0.64 |
| 6413 | DAB2 levels | GCST90468942 | 0.64 |
| 6414 | DTI TBSS L1 Posterior limb of internal capsule R | GCST90384446 | 0.64 |
| 6415 | IDP T1 FAST ROIs R postcent gyrus | GCST90002484 | 0.64 |
| 6416 | CELA3A/CPA1 ratio | GCST90314009 | 0.64 |
| 6417 | PXN levels | GCST90470396 | 0.64 |
| 6418 | SMAD3 levels | GCST90470677 | 0.64 |
| 6419 | T1 CAT WM unnormalised volume | GCST90383983 | 0.64 |
| 6420 | Mean corpuscular hemoglobin | GCST90002323 | 0.64 |
| 6421 | AFP levels | GCST90278615 | 0.64 |
| 6422 | Triacylglycerol (50:0) [NL-18:0] levels | GCST90025151 | 0.64 |
| 6423 | CTSE levels | GCST90468911 | 0.64 |
| 6424 | F-acquired taste liking (derived food-liking factor) | GCST90094791 | 0.64 |
| 6425 | ICA1 levels | GCST90469497 | 0.64 |
| 6426 | F-coffee/alcohol liking (derived food-liking factor) | GCST90094737 | 0.64 |
| 6427 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) levels (UKB data field 23402) | GCST90269499 | 0.63 |
| 6428 | Total lipid levels in LDL | GCST90092886 | 0.63 |
| 6429 | LAG3/VCAM1 ratio | GCST90315270 | 0.63 |
| 6430 | APOB levels | GCST90092809 | 0.63 |
| 6431 | CD300C/CLEC14A ratio | GCST90313786 | 0.63 |
| 6432 | CD46/TIMP1 ratio | GCST90313837 | 0.63 |
| 6433 | NUDC levels | GCST90470102 | 0.63 |
| 6434 | Lysophosphatidylcholine (24:0) [sn2] levels | GCST90024187 | 0.63 |
| 6435 | aparc-DKTatlas rh volume superiorparietal | GCST90002920 | 0.63 |
| 6436 | Hypertension | GCST90468135 | 0.63 |
| 6437 | CDKN1A/TMSB10 ratio | GCST90313978 | 0.63 |
| 6438 | CASP3 levels | GCST90468545 | 0.63 |
| 6439 | Free Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500593 | 0.63 |
| 6440 | Urate levels (UKB data field 30880) | GCST90468107 | 0.63 |
| 6441 | GDNF levels | GCST90469323 | 0.63 |
| 6442 | Number of non-cancer illnesses (standard GWA) | GCST90267290 | 0.63 |
| 6443 | Other specified/unspecified inflammatory spondylopathies | FING00001109 | 0.62 |
| 6444 | Medication use (adrenergics, inhalants) | GCST90018779 | 0.62 |
| 6445 | ICD10 N86: Erosion and ectropion of cervix uteri | GCST90454217 | 0.62 |
| 6446 | Mean volume of bilateral amygdala | GCST90474992 | 0.62 |
| 6447 | Pneumoconiosis due to other inorganic dusts | FING00001173 | 0.62 |
| 6448 | Treatment or medication use - amlodipine (UKB data field 20003_1140879802) | GCST90042195 | 0.62 |
| 6449 | Neutrophil count | GCST90002398 | 0.62 |
| 6450 | MRPL33 levels | GCST90617986 | 0.62 |
| 6451 | FABP4 levels | GCST90469176 | 0.62 |
| 6452 | Linoleic acid levels | GCST90502294 | 0.62 |
| 6453 | S100A11 levels | GCST90470512 | 0.62 |
| 6454 | T1 FreeSurfer DK rh MeanThickness thickness | GCST90385757 | 0.62 |
| 6455 | LRRN1 levels | GCST90469806 | 0.62 |
| 6456 | Alanine levels | GCST90092806 | 0.62 |
| 6457 | Degree of unsaturation | GCST90500175 | 0.62 |
| 6458 | PDGF-BB levels | GCST90428430 | 0.62 |
| 6459 | Operation code - coronary artery bypass grafts (cabg) | Operations | UKBB00000556 | 0.62 |
| 6460 | Cholesterol in medium VLDL (UKB data field 23505) | GCST90269602 | 0.62 |
| 6461 | HAVCR1 levels | GCST90012041 | 0.62 |
| 6462 | Lysophosphatidylcholine (26:0) [sn1] levels | GCST90024188 | 0.62 |
| 6463 | ADH4/RBP5 ratio | GCST90313194 | 0.62 |
| 6464 | Body fat percentage (adjusted for testosterone and SHBG) | GCST90432180 | 0.61 |
| 6465 | EDA2R levels | GCST90469067 | 0.61 |
| 6466 | Triglycerides to Total Lipids in Small HDL percentage | GCST90499530 | 0.61 |
| 6467 | F-glutamate liking (derived food-liking factor) | GCST90094772 | 0.61 |
| 6468 | Phospholipid levels in VLDL | GCST90093001 | 0.61 |
| 6469 | HJV levels | GCST90469455 | 0.61 |
| 6470 | MVK levels | GCST90469967 | 0.61 |
| 6471 | Triglycerides to Total Lipids in Small VLDL percentage | GCST90499934 | 0.61 |
| 6472 | Presence of other functional implants | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000709 | 0.61 |
| 6473 | Nontoxic multinodular goiter | endocrine/metabolic | UKBB00000528 | 0.61 |
| 6474 | ROR1/THBD ratio | GCST90315786 | 0.61 |
| 6475 | REST UKBBICA NODEamps25 0003 | GCST90385486 | 0.61 |
| 6476 | Total Lipids in VLDL | GCST90500236 | 0.61 |
| 6477 | RILP levels | GCST90470471 | 0.61 |
| 6478 | IDP dMRI TBSS MO Anterior corona radiata R | GCST90003974 | 0.61 |
| 6479 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T475 | ECGA000475 | 0.61 |
| 6480 | DTI TBSS L3 Posterior corona radiata L | GCST90384551 | 0.61 |
| 6481 | Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers) | FING00000866 | 0.61 |
| 6482 | CDKN1A/TACC3 ratio | GCST90313975 | 0.61 |
| 6483 | Saturated fatty acids levels | GCST90502658 | 0.60 |
| 6484 | PGLYRP1 levels | GCST90470219 | 0.60 |
| 6485 | PKD1 levels | GCST90470240 | 0.60 |
| 6486 | Docosahexaenoic acid levels | GCST90501978 | 0.60 |
| 6487 | CSF2RB levels | GCST90468883 | 0.60 |
| 6488 | Degree of unsaturation | GCST90502231 | 0.60 |
| 6489 | VEGFA levels | GCST90471034 | 0.60 |
| 6490 | ADIPOQ levels | GCST90293086 | 0.60 |
| 6491 | Takes medication for heart attack? | GCST90475212 | 0.60 |
| 6492 | CFB levels | GCST90240778 | 0.60 |
| 6493 | Atrial septal defect | FING00000128 | 0.60 |
| 6494 | Major dietary changes in the last 5 years - Yes, because of other reasons | Diet | UKBB00000423 | 0.60 |
| 6495 | Obesity (PheCode 278.1) | GCST90475762 | 0.60 |
| 6496 | ADGRG2/ITGB1 ratio | GCST90313185 | 0.60 |
| 6497 | Triglyceride to phosphoglyceride ratio | GCST90499992 | 0.60 |
| 6498 | BAX levels | GCST90468424 | 0.60 |
| 6499 | Fracture of lower leg, including ankle | FING00000555 | 0.60 |
| 6500 | Phosphatidylcholine acyl-alkyl C36:5 levels | GCST90240073 | 0.60 |
| 6501 | F-highly palatable foods liking (derived food-liking factor) | GCST90094785 | 0.60 |
| 6502 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T219 | ECGU000219 | 0.60 |
| 6503 | DTI TBSS L2 Fornix | GCST90384481 | 0.60 |
| 6504 | CLSTN2 levels | GCST90468789 | 0.60 |
| 6505 | IDP dMRI TBSS ISOVF Superior longitudinal fasciculus L | GCST90004518 | 0.59 |
| 6506 | EBAG9/TBCC ratio | GCST90314568 | 0.59 |
| 6507 | CDH17/PTPRM ratio | GCST90313943 | 0.59 |
| 6508 | Male-pattern baldness | GCST006661 | 0.59 |
| 6509 | ADGRG2/SDC1 ratio | GCST90313187 | 0.59 |
| 6510 | DAPK2 levels | GCST90240877 | 0.59 |
| 6511 | CA1 levels | GCST90468510 | 0.59 |
| 6512 | Free cholesterol in medium VLDL (UKB data field 23507) | GCST90269604 | 0.59 |
| 6513 | Primary gonarthrosis, bilateral | FING00001213 | 0.59 |
| 6514 | TREML2 levels | GCST90470962 | 0.59 |
| 6515 | AMY1A or AMY1B or AMY1C levels | GCST90468297 | 0.59 |
| 6516 | CPE levels | GCST90468841 | 0.59 |
| 6517 | Blood cell traits latent factor 23 (white cell) | GCST90559265 | 0.59 |
| 6518 | RILPL2 levels | GCST90470470 | 0.59 |
| 6519 | Immature fraction of reticulocytes | GCST004628 | 0.59 |
| 6520 | MAX/TDRKH ratio | GCST90315406 | 0.59 |
| 6521 | Neurofibromatosis, type 2 | FING00000867 | 0.59 |
| 6522 | SLA2 levels | GCST90470648 | 0.58 |
| 6523 | estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed) | GCST90475285 | 0.58 |
| 6524 | SERPINB1/TMSB10 ratio | GCST90315830 | 0.58 |
| 6525 | Number of diet questionnaires completed | Diet questionnaire performance | UKBB00000536 | 0.58 |
| 6526 | CEP85/ZBTB16 ratio | GCST90314026 | 0.58 |
| 6527 | Volume of right paralaminar nucleus | GCST90475048 | 0.58 |
| 6528 | HSD17B14 levels | GCST90469483 | 0.58 |
| 6529 | Immature reticulocyte fraction (UKB data field 30280) | GCST90468079 | 0.58 |
| 6530 | Parkinson's disease or first degree relation to individual with Parkinson's disease | GCST009325 | 0.58 |
| 6531 | Haematocrit percentage | Blood count | UKBB00000292 | 0.58 |
| 6532 | CLC/RNASE3 ratio | GCST90314077 | 0.58 |
| 6533 | BST2/CEACAM1 ratio | GCST90313537 | 0.58 |
| 6534 | CES3 levels | GCST90468720 | 0.58 |
| 6535 | Tea difference liking | GCST90094855 | 0.58 |
| 6536 | Cholesteryl ester levels in LDL | GCST90092884 | 0.58 |
| 6537 | Osteoarthritis | GCST90476383 | 0.58 |
| 6538 | Cholesteryl Esters in Medium LDL | GCST90498738 | 0.58 |
| 6539 | Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500333 | 0.58 |
| 6540 | ENG levels | GCST90469108 | 0.58 |
| 6541 | aparc-a2009s rh area S-collat-transv-ant | GCST90003420 | 0.58 |
| 6542 | aseg global intensity WM-hypointensities | GCST90003756 | 0.58 |
| 6543 | Hematocrit | GCST90018740 | 0.58 |
| 6544 | Prostate cancer | GCST90018685 | 0.57 |
| 6545 | DBNL/DNAJA2 ratio | GCST90314415 | 0.57 |
| 6546 | Calculus of kidney and ureter | Urolithiasis | UKBB00000116 | 0.57 |
| 6547 | DCN levels | GCST90468956 | 0.57 |
| 6548 | T1 CAT volume Vermis VIIIa | GCST90384128 | 0.57 |
| 6549 | CCDC80 levels | GCST90468562 | 0.57 |
| 6550 | DDR1/SFTPD ratio | GCST90314443 | 0.57 |
| 6551 | Behaviour of cancer tumour: malignant, primary site, PHESANT recoding (UKB data field 40012_3) | GCST90043946 | 0.57 |
| 6552 | CXCL16 levels | GCST90012059 | 0.57 |
| 6553 | Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | Medication | UKBB00000455 | 0.57 |
| 6554 | Plasma sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* levels in chronic kidney disease | GCST90265971 | 0.57 |
| 6555 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92) | GCST90320655 | 0.57 |
| 6556 | COL24A1 levels | GCST90468814 | 0.57 |
| 6557 | F-low caloric food liking (derived food-liking factor) | GCST90094795 | 0.57 |
| 6558 | Cholesteryl esters to total lipids in small HDL percentage (UKB data field 23646) | GCST90269743 | 0.57 |
| 6559 | Free cholesterol in IDL (UKB data field 23528) | GCST90269625 | 0.57 |
| 6560 | Docosahexaenoic acid to total fatty acids percentage | GCST90497268 | 0.57 |
| 6561 | T1 CAT volume L TemporalOccipitalFusiformCortex | GCST90384076 | 0.57 |
| 6562 | Concentration of LDL particles | GCST90092887 | 0.57 |
| 6563 | Phospholipids to Total Lipids in Large VLDL percentage | GCST90498258 | 0.57 |
| 6564 | CALCOCO1/METAP2 ratio | GCST90313606 | 0.57 |
| 6565 | aparc-DKTatlas rh area superiorparietal | GCST90003292 | 0.57 |
| 6566 | DNAJB1/STIP1 ratio | GCST90314513 | 0.57 |
| 6567 | Other disorders of circulatory system | circulatory system | UKBB00000607 | 0.56 |
| 6568 | CXCL6 levels | GCST90468933 | 0.56 |
| 6569 | Massiliomicrobiota abundance in stool | GCST90032470 | 0.56 |
| 6570 | CXCL5/PPIB ratio | GCST90314352 | 0.56 |
| 6571 | Phospholipids in medium HDL (UKB data field 23567) | GCST90269664 | 0.56 |
| 6572 | Cholesteryl ester levels in large LDL | GCST90092858 | 0.56 |
| 6573 | Free Cholesterol to Total Lipids in Small VLDL percentage | GCST90499832 | 0.56 |
| 6574 | Other hypertrophic and atrophic conditions (PheCode 701) | GCST90476197 | 0.56 |
| 6575 | GALNT10/IGSF3 ratio | GCST90314914 | 0.56 |
| 6576 | PODXL2/SCG3 ratio | GCST90315700 | 0.56 |
| 6577 | CDSN/WFDC12 ratio | GCST90313999 | 0.56 |
| 6578 | SEMA4D/TREML2 ratio | GCST90315823 | 0.56 |
| 6579 | Patient classification on admission (recoded) - Inpatient | Summary Administration | UKBB00000637 | 0.56 |
| 6580 | Concentration of small VLDL particles (UKB data field 23509) | GCST90269606 | 0.55 |
| 6581 | ENPP2 levels | GCST90469115 | 0.55 |
| 6582 | EGFLAM levels | GCST90469084 | 0.55 |
| 6583 | ENPP5 levels | GCST90469116 | 0.55 |
| 6584 | DTI TBSS L3 Fornix | GCST90384529 | 0.55 |
| 6585 | TF levels | GCST90470841 | 0.55 |
| 6586 | Mental and behavioural disorders due to use of other stimulants, including caffeine | FING00000811 | 0.55 |
| 6587 | CLPP/DECR1 ratio | GCST90314137 | 0.55 |
| 6588 | ARHGAP45 levels | GCST90468355 | 0.55 |
| 6589 | Heart failure | GCST90399712 | 0.55 |
| 6590 | eGFR in diabetes mellitus (full adjustment) | GCST90624786 | 0.55 |
| 6591 | Diacylglycerol_34:1_[M+H-H2O]1+ levels | GCST90060179 | 0.55 |
| 6592 | Age-related macular degeneration (whether dry or wet) | FING00000047 | 0.55 |
| 6593 | Free Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498988 | 0.55 |
| 6594 | ADAMTSL5 levels | GCST90468230 | 0.55 |
| 6595 | KLK8/WFDC12 ratio | GCST90315259 | 0.55 |
| 6596 | Urine andro steroid monosulfate C19H28O6S (1)* levels in chronic kidney disease | GCST90264796 | 0.55 |
| 6597 | IDP dMRI TBSS L3 Genu of corpus callosum | GCST90004173 | 0.54 |
| 6598 | PROK1 levels | GCST90470336 | 0.54 |
| 6599 | Free cholesterol levels in medium VLDL | GCST90092920 | 0.54 |
| 6600 | Peptic ulcer (excl. esophageal) | digestive | UKBB00000639 | 0.54 |
| 6601 | Neutrophill count (UKB data field 30140) | GCST90468092 | 0.54 |
| 6602 | Spirits liking | GCST90094848 | 0.54 |
| 6603 | INSR levels | GCST90469623 | 0.54 |
| 6604 | Operative procedures - No procedure performed | Summary Operations | UKBB00000584 | 0.54 |
| 6605 | LGALS3 levels | GCST90469761 | 0.54 |
| 6606 | Diastolic blood pressure | GCST90025981 | 0.54 |
| 6607 | Total lipid levels in medium VLDL | GCST90092922 | 0.54 |
| 6608 | Phospholipids in VLDL | GCST90500266 | 0.54 |
| 6609 | PRUNE2 levels | GCST90470349 | 0.54 |
| 6610 | FAM20A levels | GCST90469185 | 0.54 |
| 6611 | Cholesterol to total lipids in large HDL percentage (UKB data field 23635) | GCST90269732 | 0.54 |
| 6612 | Blood urea nitrogen (BUN, mean, inv-norm transformed) | GCST90475165 | 0.54 |
| 6613 | Triglycerides in very large HDL (UKB data field 23557) | GCST90269654 | 0.54 |
| 6614 | DTI autoptx L2 unc r tract | GCST90385192 | 0.54 |
| 6615 | aparc-a2009s lh thickness S-intrapariet+P-trans | GCST90003658 | 0.54 |
| 6616 | Chronic nephritic syndrome | FING00000295 | 0.53 |
| 6617 | Linoleic acid levels | GCST90502306 | 0.53 |
| 6618 | Never eat wheat vs no wheat restrictions (UKB data field 6144) | GCST90132932 | 0.53 |
| 6619 | hemoglobin (mean, inv-norm transformed) | GCST90475374 | 0.53 |
| 6620 | Phospholipids to total lipids ratio in small LDL | GCST90092965 | 0.53 |
| 6621 | BACH1/SNX9 ratio | GCST90313447 | 0.53 |
| 6622 | T1 FreeSurfer a2009s lh S postcentral volume | GCST90384882 | 0.53 |
| 6623 | TPK1 levels | GCST90470943 | 0.53 |
| 6624 | FKBP4 levels | GCST90469243 | 0.53 |
| 6625 | aparc-Desikan lh area parstriangularis | GCST90003092 | 0.53 |
| 6626 | Crisps liking | GCST90094747 | 0.53 |
| 6627 | RNF43 levels | GCST90422482 | 0.53 |
| 6628 | BCAM/EPO ratio | GCST90313471 | 0.53 |
| 6629 | IL17RB levels | GCST90469563 | 0.53 |
| 6630 | X-04499--3,4-dihydroxybutyrate levels | GCST90243497 | 0.53 |
| 6631 | CD248 levels | GCST90468612 | 0.53 |
| 6632 | red blood cell count (RBC, minimum, inv-norm transformed) | GCST90476353 | 0.53 |
| 6633 | Avocado liking | GCST90094694 | 0.53 |
| 6634 | Diacylglycerol (14:0_18:2) levels | GCST90024705 | 0.53 |
| 6635 | CRTAP levels | GCST90468872 | 0.53 |
| 6636 | Pizza liking | GCST90094810 | 0.53 |
| 6637 | CASP3/SERPINB9 ratio | GCST90313642 | 0.53 |
| 6638 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502648 | 0.53 |
| 6639 | Juvenile rheumatoid arthirtis | FING00000706 | 0.52 |
| 6640 | SPRR3 levels | GCST90470737 | 0.52 |
| 6641 | IL6R levels | GCST90469602 | 0.52 |
| 6642 | CCL17 levels | GCST90468569 | 0.52 |
| 6643 | FLT4/ICAM2 ratio | GCST90314860 | 0.52 |
| 6644 | Unspecified monoarthritis | musculoskeletal | UKBB00000882 | 0.52 |
| 6645 | F-oily fish liking (derived food-liking factor) | GCST90094804 | 0.52 |
| 6646 | SHBG levels | GCST90503315 | 0.52 |
| 6647 | CETN2 levels | GCST90468721 | 0.52 |
| 6648 | CD99L2 levels | GCST90468657 | 0.52 |
| 6649 | Excessive sweating | GCST006090 | 0.52 |
| 6650 | NTF3 levels | GCST90470094 | 0.52 |
| 6651 | Docosahexaenoic acid levels | GCST90502254 | 0.52 |
| 6652 | S100A14 levels | GCST90470515 | 0.52 |
| 6653 | Diacylglycerol_34:0_[M+H-H2O]1+ levels | GCST90060181 | 0.52 |
| 6654 | CD84/DAG1 ratio | GCST90313910 | 0.52 |
| 6655 | TDRKH levels | GCST90470827 | 0.52 |
| 6656 | Atrial fibrillation (MTAG) | GCST90449054 | 0.52 |
| 6657 | T1 FreeSurfer DK rh cuneus area | GCST90385693 | 0.52 |
| 6658 | LDL cholesterol levels | GCST90092883 | 0.52 |
| 6659 | Number of sexual partners in opposite-sex sexual behavior | GCST90026481 | 0.52 |
| 6660 | Emotional abuse | GCST90551845 | 0.52 |
| 6661 | GPKOW levels | GCST90469392 | 0.52 |
| 6662 | Cholesteryl Esters to Total Lipids in Very Large VLDL percentage | GCST90500565 | 0.51 |
| 6663 | 3-methyl-2-oxobutyrate levels | GCST90199677 | 0.51 |
| 6664 | Postmenopausal breast cancer | GCST90428116 | 0.51 |
| 6665 | Prescriptions - ACE inhibitor|anti-hypertensive | UKBB00000657 | 0.51 |
| 6666 | aparc-DKTatlas rh thickness transversetemporal | GCST90003601 | 0.51 |
| 6667 | ITGB1BP2/WASF1 ratio | GCST90315224 | 0.51 |
| 6668 | Basal cell carcinoma | GCST90468114 | 0.51 |
| 6669 | Haemorrhoids and perianal venous thrombosis | FING00000599 | 0.51 |
| 6670 | Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636) | GCST90269733 | 0.51 |
| 6671 | PRELP levels | GCST90470321 | 0.51 |
| 6672 | EIF4G1/HEXIM1 ratio | GCST90314635 | 0.51 |
| 6673 | Concentration of small VLDL particles | GCST90499856 | 0.51 |
| 6674 | Polyunsaturated fatty acid levels | GCST90502618 | 0.51 |
| 6675 | F13B levels | GCST90469167 | 0.51 |
| 6676 | Triacylglycerol_52:2_[M+NH4]1+ levels | GCST90060511 | 0.50 |
| 6677 | ESR1 levels | GCST90469155 | 0.50 |
| 6678 | ASPSCR1 levels | GCST90468378 | 0.50 |
| 6679 | Prostate cancer | GCST90274714 | 0.50 |
| 6680 | STMN3 levels | GCST90242894 | 0.50 |
| 6681 | CTRL levels | GCST90468907 | 0.50 |
| 6682 | Atrial fibrillation | GCST006414 | 0.50 |
| 6683 | NUDT5/RWDD1 ratio | GCST90315580 | 0.50 |
| 6684 | Volume of left central nucleus | GCST90474883 | 0.50 |
| 6685 | TTN levels | GCST90470984 | 0.50 |
| 6686 | MED18/TBL1X ratio | GCST90315415 | 0.50 |
| 6687 | ICD10 C61: Malignant neoplasm of prostate | GCST90043894 | 0.50 |
| 6688 | IL1R2 levels | GCST90469572 | 0.50 |
| 6689 | UMOD levels | GCST90471009 | 0.50 |
| 6690 | Alanine transaminase (ALT, maximum, inv-norm transformed) | GCST90475109 | 0.50 |
| 6691 | NEXN levels | GCST90470030 | 0.50 |
| 6692 | DTI TBSS L1 Anterior corona radiata L | GCST90384451 | 0.50 |
| 6693 | CLEC4G/MERTK ratio | GCST90314121 | 0.50 |
| 6694 | Skin and soft tissue infections | GCST90013411 | 0.50 |
| 6695 | SARG levels | GCST90470526 | 0.50 |
| 6696 | CCL17/CD69 ratio | GCST90313684 | 0.50 |
| 6697 | Platelet crit | Blood count | UKBB00000647 | 0.50 |
| 6698 | LEPR/NRCAM ratio | GCST90315312 | 0.50 |
| 6699 | wg rh intensity-contrast cuneus | GCST90003831 | 0.50 |
| 6700 | IDP dMRI ProbtrackX L1 slf r | GCST90004268 | 0.50 |
| 6701 | CD22/FOLR2 ratio | GCST90313758 | 0.50 |
| 6702 | CD38/RELT ratio | GCST90313809 | 0.50 |
| 6703 | Phospholipids to Total Lipids in Very Small VLDL percentage | GCST90500866 | 0.49 |
| 6704 | IL12RB1 levels | GCST90469550 | 0.49 |
| 6705 | GGCT levels | GCST90469334 | 0.49 |
| 6706 | Treatment/medication code - salbutamol | Medications | UKBB00000857 | 0.49 |
| 6707 | Triglycerides to Total Lipids in Large LDL percentage | GCST90498101 | 0.49 |
| 6708 | IDP T1 FAST ROIs L ventral striatum | GCST90002559 | 0.49 |
| 6709 | Stearate 18:0 levels | GCST90243431 | 0.49 |
| 6710 | CD200/CLEC4G ratio | GCST90313746 | 0.49 |
| 6711 | Total cholesterol minus HDL-C levels (UKB data field 23401) | GCST90269498 | 0.49 |
| 6712 | Frequency of solarium/sunlamp use | Sun exposure | UKBB00000265 | 0.49 |
| 6713 | IDP dMRI TBSS FA Genu of corpus callosum | GCST90003879 | 0.49 |
| 6714 | aparc-a2009s rh area G-oc-temp-lat-fusifor | GCST90003391 | 0.49 |
| 6715 | HippSubfield rh volume Whole-hippocampus | GCST90002711 | 0.49 |
| 6716 | AmygNuclei rh volume Accessory-Basal-nucleus | GCST90002660 | 0.49 |
| 6717 | Triglycerides to Total Lipids in IDL percentage | GCST90497682 | 0.49 |
| 6718 | FAM3B/FGF19 ratio | GCST90314776 | 0.49 |
| 6719 | Other and unspecified anaemias | FING00000925 | 0.49 |
| 6720 | LTBR levels | GCST90469816 | 0.49 |
| 6721 | DTI TBSS MD Cingulum cingulate gyrus L | GCST90384607 | 0.49 |
| 6722 | Free Cholesterol to Total Lipids in Large VLDL percentage | GCST90498199 | 0.49 |
| 6723 | Retinal arteriolar width | GCST90270398 | 0.49 |
| 6724 | Internal derangement of knee | FING00000684 | 0.48 |
| 6725 | Concentration of large LDL particles | GCST90092863 | 0.48 |
| 6726 | Cystatin C levels in bottom 99% of individuals by creatinine levels | GCST90566734 | 0.48 |
| 6727 | ADGRG2 levels | GCST90468241 | 0.48 |
| 6728 | GRHPR levels | GCST90469400 | 0.48 |
| 6729 | LGALS4/PCDH17 ratio | GCST90315315 | 0.48 |
| 6730 | Trouble falling asleep when you first go to bed | GCST90476385 | 0.48 |
| 6731 | Other bacterial intestinal infections | FING00000969 | 0.48 |
| 6732 | Total testosterone levels | GCST90239820 | 0.48 |
| 6733 | Total lipids in small VLDL (UKB data field 23510) | GCST90269607 | 0.48 |
| 6734 | Cholesteryl Esters in Medium LDL | GCST90498739 | 0.48 |
| 6735 | Osteomyelitis | FING00000911 | 0.48 |
| 6736 | Left-hemisphere dorsal attention network to thalamus white-matter structural connectivity | GCST90302701 | 0.48 |
| 6737 | PAEP levels | GCST90470144 | 0.48 |
| 6738 | Tryptophan levels | GCST90243403 | 0.48 |
| 6739 | Other mental disorders due to brain damage and dysfunction and to physical disease | FING00001072 | 0.48 |
| 6740 | Right hippocampal volume (tail) | GCST90267973 | 0.48 |
| 6741 | Estimated glomerular filtration rate based on creatinine and cystatin C in bottom 99% of individuals by creatinine levels | GCST90566737 | 0.48 |
| 6742 | Omega-3 fatty acids to total fatty acids percentage | GCST90499163 | 0.48 |
| 6743 | Right-hemisphere visual network to right-hemisphere visual network white-matter structural connectivity | GCST90302774 | 0.47 |
| 6744 | Citrate levels (UKB data field 23473) | GCST90269570 | 0.47 |
| 6745 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502596 | 0.47 |
| 6746 | Volume of left cortico-amygdaloid transition area | GCST90474880 | 0.47 |
| 6747 | CCL18/TFPI ratio | GCST90313691 | 0.47 |
| 6748 | ITGB1BP2/TIA1 ratio | GCST90315222 | 0.47 |
| 6749 | Chronic sinusitis (PheCode 475) | GCST90476020 | 0.47 |
| 6750 | Cardiac conduction disorders (PheCode 426) | GCST90475952 | 0.47 |
| 6751 | Omega-6 fatty acid levels | GCST90502101 | 0.47 |
| 6752 | ADAMTS8 levels | GCST90468227 | 0.47 |
| 6753 | NECTIN2/SPON2 ratio | GCST90315530 | 0.47 |
| 6754 | Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels | GCST90060295 | 0.47 |
| 6755 | Immature reticulocyte fraction | Blood count | UKBB00000355 | 0.47 |
| 6756 | LYN/SIRT2 ratio | GCST90315349 | 0.47 |
| 6757 | DSG2 levels | GCST90427825 | 0.46 |
| 6758 | Linoleic acid to total fatty acids percentage | GCST90502337 | 0.46 |
| 6759 | Concentration of small LDL particles (UKB data field 23544) | GCST90269641 | 0.46 |
| 6760 | NRCAM/NTRK2 ratio | GCST90315552 | 0.46 |
| 6761 | ALKBH3 levels | GCST90619095 | 0.46 |
| 6762 | Free cholesterol in small VLDL (UKB data field 23514) | GCST90269611 | 0.46 |
| 6763 | Degree of unsaturation | GCST90502736 | 0.46 |
| 6764 | PTPN6/YES1 ratio | GCST90315750 | 0.46 |
| 6765 | ICD10 N97.0: Female infertility associated with anovulation | GCST90454223 | 0.46 |
| 6766 | HS6ST1/MEGF9 ratio | GCST90315081 | 0.46 |
| 6767 | Total lipid levels in lipoprotein particles | GCST90500085 | 0.46 |
| 6768 | Cholesterol levels in medium LDL | GCST90092904 | 0.46 |
| 6769 | LILRA2 levels | GCST90469771 | 0.46 |
| 6770 | DTNB levels | GCST90469046 | 0.46 |
| 6771 | MAVS/MYO9B ratio | GCST90315390 | 0.46 |
| 6772 | MAD1L1/POLR2F ratio | GCST90315354 | 0.46 |
| 6773 | PRTN3 levels | GCST90470348 | 0.46 |
| 6774 | IRAK4 levels | GCST90469628 | 0.46 |
| 6775 | Phospholipids in large VLDL | GCST90498247 | 0.46 |
| 6776 | Appendectomy | FING00000104 | 0.46 |
| 6777 | SHBG levels | GCST90470622 | 0.46 |
| 6778 | MOCS2 levels | GCST90469928 | 0.46 |
| 6779 | Total cholesterol levels | GCST90278644 | 0.46 |
| 6780 | Concentration of HDL particles (UKB data field 23430) | GCST90269527 | 0.46 |
| 6781 | Salmon liking | GCST90094826 | 0.46 |
| 6782 | Linoleic acid to total fatty acids percentage | GCST90498321 | 0.46 |
| 6783 | CCN5/IGFBP6 ratio | GCST90313723 | 0.46 |
| 6784 | APOB levels | GCST90269536 | 0.46 |
| 6785 | Triglycerides to total lipids ratio in medium HDL | GCST90092903 | 0.46 |
| 6786 | STAMBP levels | GCST90470756 | 0.45 |
| 6787 | Principal component-derived dietary pattern 26 | GCST90133031 | 0.45 |
| 6788 | F9/PROC ratio | GCST90314748 | 0.45 |
| 6789 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76) | GCST90320639 | 0.45 |
| 6790 | Cholesteryl esters in medium VLDL (UKB data field 23506) | GCST90269603 | 0.45 |
| 6791 | VLDL cholesterol levels (UKB data field 23403) | GCST90269500 | 0.45 |
| 6792 | Concentration of VLDL particles | GCST90093000 | 0.45 |
| 6793 | Left-hemisphere default mode network to amygdala white-matter structural connectivity | GCST90302772 | 0.45 |
| 6794 | APOB levels | UKBB00000041 | 0.45 |
| 6795 | aparc-pial lh area parstriangularis | GCST90003160 | 0.45 |
| 6796 | ITGA5/VCAM1 ratio | GCST90315206 | 0.45 |
| 6797 | Prescriptions - bendroflumethiazide | thiazide diuretic,diuretic | UKBB00000667 | 0.45 |
| 6798 | T1 FreeSurfer DK rh cuneus volume | GCST90385761 | 0.44 |
| 6799 | CD69 levels | GCST90468643 | 0.44 |
| 6800 | Colon cancer | GCST90011811 | 0.44 |
| 6801 | ADGRE2 levels | GCST90468237 | 0.44 |
| 6802 | GSTT2 levels | GCST90086652 | 0.44 |
| 6803 | Total lipids in small VLDL | GCST90499840 | 0.44 |
| 6804 | Medication for pain relief, constipation, heartburn - Aspirin | Medication | UKBB00000454 | 0.44 |
| 6805 | Haemoglobin concentration | Blood count | UKBB00000293 | 0.44 |
| 6806 | NUCB2/RSPO3 ratio | GCST90315575 | 0.44 |
| 6807 | Treatment or medication use - rosuvastatin (UKB data field 20003_1141192410) | GCST90042539 | 0.44 |
| 6808 | GSTA4 levels | GCST90241283 | 0.44 |
| 6809 | High light scatter reticulocyte count (UKB data field 30300) | GCST90468076 | 0.44 |
| 6810 | aparc-Desikan rh thickness transversetemporal | GCST90003511 | 0.44 |
| 6811 | ZP3 levels | GCST90471105 | 0.44 |
| 6812 | PPY levels | GCST90470309 | 0.44 |
| 6813 | Concentration of medium LDL particles (UKB data field 23537) | GCST90269634 | 0.44 |
| 6814 | CD79B/FCRL2 ratio | GCST90313900 | 0.44 |
| 6815 | Bleeding | FING00000219 | 0.44 |
| 6816 | wg rh intensity-contrast bankssts | GCST90003828 | 0.44 |
| 6817 | Triglycerides to total lipids in large HDL percentage (UKB data field 23638) | GCST90269735 | 0.44 |
| 6818 | neutrophil (absolute count, maximum, inv-norm transformed) | GCST90475526 | 0.44 |
| 6819 | Cholesteryl esters in VLDL (UKB data field 23416) | GCST90269513 | 0.44 |
| 6820 | Felt very upset when reminded of stressful experience in past month | Traumatic events | UKBB00000243 | 0.44 |
| 6821 | BCAM/SEMA7A ratio | GCST90313476 | 0.43 |
| 6822 | CD58/ROR1 ratio | GCST90313854 | 0.43 |
| 6823 | HDL x low social support interaction (2df test) | GCST90570669 | 0.43 |
| 6824 | Total lipids in medium HDL (UKB data field 23566) | GCST90269663 | 0.43 |
| 6825 | Cancer code, self-reported - basal cell carcinoma | Medical conditions | UKBB00000117 | 0.43 |
| 6826 | CNPY4/STAT5B ratio | GCST90314155 | 0.43 |
| 6827 | aparc-a2009s rh volume S-collat-transv-ant | GCST90003048 | 0.43 |
| 6828 | Total phospholipid levels in lipoprotein particles | GCST90092991 | 0.43 |
| 6829 | REG1A/REG4 ratio | GCST90315762 | 0.43 |
| 6830 | PNLIPRP2 levels | GCST90470274 | 0.43 |
| 6831 | CCL15 levels | GCST90468567 | 0.43 |
| 6832 | NECTIN2/TNFRSF14 ratio | GCST90315531 | 0.43 |
| 6833 | DTI TBSS L1 Anterior corona radiata R | GCST90384450 | 0.43 |
| 6834 | C1QTNF1/COL18A1 ratio | GCST90313551 | 0.43 |
| 6835 | CD200R1 levels | GCST90468605 | 0.43 |
| 6836 | EDAR/ITGB1BP2 ratio | GCST90314580 | 0.43 |
| 6837 | 10-undecenoate (11:1n1) levels | GCST90243596 | 0.43 |
| 6838 | PTGR1 levels | GCST90470370 | 0.42 |
| 6839 | MINDY1 levels | GCST90469908 | 0.42 |
| 6840 | DNAJA2/FIS1 ratio | GCST90314501 | 0.42 |
| 6841 | Hernia of abdominal wall | FING00000617 | 0.42 |
| 6842 | PLXNB3 levels | GCST90470267 | 0.42 |
| 6843 | BAX/MAX ratio | GCST90313466 | 0.42 |
| 6844 | DCBLD2/PLA2G15 ratio | GCST90314428 | 0.42 |
| 6845 | TNFRSF21 levels | GCST90470912 | 0.42 |
| 6846 | Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302700 | 0.42 |
| 6847 | Concentration of IDL particles (UKB data field 23523) | GCST90269620 | 0.42 |
| 6848 | SDHB levels | GCST90470561 | 0.42 |
| 6849 | N-acetyltaurine levels | GCST90199967 | 0.42 |
| 6850 | Cardiovascular diseases (excluding rheumatic etc) | FING00000255 | 0.42 |
| 6851 | DTI autoptx MD ifo l tract | GCST90385232 | 0.42 |
| 6852 | MSMB levels | GCST90469949 | 0.42 |
| 6853 | Cholesteryl Esters in Small HDL | GCST90499382 | 0.42 |
| 6854 | F-healthy breakfast food liking (derived food-liking factor) | GCST90094780 | 0.42 |
| 6855 | Family relationship satisfaction | Mental health | UKBB00000238 | 0.42 |
| 6856 | PAEP/RSPO1 ratio | GCST90315593 | 0.42 |
| 6857 | ESM1 levels | GCST90469153 | 0.42 |
| 6858 | DBI levels | GCST90468949 | 0.42 |
| 6859 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 74) | GCST90320637 | 0.42 |
| 6860 | Butyrylcarnitine levels | GCST90243589 | 0.42 |
| 6861 | Septal defects | FING00001293 | 0.42 |
| 6862 | DCTPP1 levels | GCST90468961 | 0.42 |
| 6863 | CRADD/EREG ratio | GCST90314236 | 0.42 |
| 6864 | T1 FreeSurfer DK rh superiorparietal thickness | GCST90385751 | 0.41 |
| 6865 | Cholelithiasis | digestive | UKBB00000131 | 0.41 |
| 6866 | CERT levels | GCST90468717 | 0.41 |
| 6867 | Immature fraction of reticulocytes | GCST90002387 | 0.41 |
| 6868 | REG1A/TFF3 ratio | GCST90315764 | 0.41 |
| 6869 | DNA methylation-estimated granulocyte proportions | GCST90014287 | 0.41 |
| 6870 | STXBP1 levels | GCST90470777 | 0.41 |
| 6871 | aparc-a2009s rh area G-oc-temp-med-Lingual | GCST90003392 | 0.41 |
| 6872 | HSPB1 levels | GCST90179317 | 0.41 |
| 6873 | DSG3 levels | GCST90469043 | 0.41 |
| 6874 | HPCAL1 levels | GCST90469471 | 0.41 |
| 6875 | CLEC1A levels | GCST90468767 | 0.41 |
| 6876 | PON2 levels | GCST90470286 | 0.41 |
| 6877 | LBR/LGALS8 ratio | GCST90315294 | 0.41 |
| 6878 | Total fatty acid levels | GCST90092987 | 0.41 |
| 6879 | FCRL1/TNFRSF13C ratio | GCST90314796 | 0.41 |
| 6880 | Myocardial fractal dimension (slice 2) | GCST90000288 | 0.41 |
| 6881 | EFNA1 levels | GCST90469080 | 0.41 |
| 6882 | Omega-3 fatty acid levels | GCST90502437 | 0.41 |
| 6883 | CCL13/CCL8 ratio | GCST90313676 | 0.41 |
| 6884 | S100P levels | GCST90470520 | 0.41 |
| 6885 | Unspecified/other endometriosis | FING00001404 | 0.41 |
| 6886 | CD79B/ICAM3 ratio | GCST90313901 | 0.41 |
| 6887 | SCN4B levels | GCST90470551 | 0.41 |
| 6888 | High light scatter reticulocyte percentage (UKB data field 30290) | GCST90468077 | 0.41 |
| 6889 | GP6/SEMA4D ratio | GCST90314971 | 0.41 |
| 6890 | Breast cancer | GCST007236 | 0.40 |
| 6891 | Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levels | GCST90060557 | 0.40 |
| 6892 | AMBP/EFEMP1 ratio | GCST90313253 | 0.40 |
| 6893 | MAVS/RNF41 ratio | GCST90315395 | 0.40 |
| 6894 | Follicle stimulating hormone levels | GCST90483476 | 0.40 |
| 6895 | Cholesterol to total lipids ratio in medium HDL | GCST90092893 | 0.40 |
| 6896 | Concentration of medium VLDL particles | GCST90092923 | 0.40 |
| 6897 | GP6/SCARF1 ratio | GCST90314969 | 0.40 |
| 6898 | CST1 levels | GCST90468893 | 0.40 |
| 6899 | IDP dMRI ProbtrackX FA atr r | GCST90003928 | 0.40 |
| 6900 | MAP4K5 levels | GCST90469855 | 0.40 |
| 6901 | CD74/LILRB4 ratio | GCST90313894 | 0.40 |
| 6902 | Aspartate aminotransferase (AST, mean, inv-norm transformed) | GCST90475121 | 0.40 |
| 6903 | triglyceride (maximum, inv-norm transformed) | GCST90476431 | 0.40 |
| 6904 | Urine glucuronide of C10H18O2 (12)* levels in chronic kidney disease | GCST90265189 | 0.40 |
| 6905 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T220 | ECGU000220 | 0.40 |
| 6906 | Other diseases of upper respiratory tract | FING00001012 | 0.40 |
| 6907 | Succinylcarnitine levels | GCST90243874 | 0.40 |
| 6908 | Concentration of large LDL particles (UKB data field 23530) | GCST90269627 | 0.40 |
| 6909 | aseg global volume VentricleChoroid | GCST90002598 | 0.40 |
| 6910 | aparc-DKTatlas lh area parstriangularis | GCST90003252 | 0.39 |
| 6911 | Free cholesterol levels in VLDL | GCST90092998 | 0.39 |
| 6912 | Sebaceous cyst (PheCode 706.2) | GCST90476213 | 0.39 |
| 6913 | Worry too long after embarrassment | Mental health | UKBB00000922 | 0.39 |
| 6914 | Skin brightness | GCST90502777 | 0.39 |
| 6915 | Phospholipid levels in medium VLDL | GCST90092924 | 0.39 |
| 6916 | Phospholipids to total lipids ratio in IDL | GCST90092840 | 0.39 |
| 6917 | CETN2/PRTFDC1 ratio | GCST90314030 | 0.39 |
| 6918 | IDP dMRI TBSS MO Fornix | GCST90003957 | 0.39 |
| 6919 | Moderate to vigorous physical activity duration | GCST90061422 | 0.39 |
| 6920 | MOG/SEZ6L ratio | GCST90315477 | 0.39 |
| 6921 | Allergic rhinitis | GCST90086042 | 0.39 |
| 6922 | Cholesteryl Esters to Total Lipids in Very Large HDL percentage | GCST90500373 | 0.39 |
| 6923 | HS6ST1 levels | GCST90469479 | 0.39 |
| 6924 | ITPA levels | GCST90469654 | 0.39 |
| 6925 | Free Cholesterol in HDL | GCST90497379 | 0.39 |
| 6926 | GHRL levels | GCST90469341 | 0.39 |
| 6927 | Phospholipids in medium VLDL (UKB data field 23504) | GCST90269601 | 0.39 |
| 6928 | Free Cholesterol in VLDL | GCST90500221 | 0.39 |
| 6929 | Obesity due to excess calories | FING00000896 | 0.39 |
| 6930 | FURIN levels | GCST90469277 | 0.39 |
| 6931 | LDLR/PCSK9 ratio | GCST90315311 | 0.39 |
| 6932 | FLT1 levels | GCST90469249 | 0.39 |
| 6933 | Monoclonal gammopathy of undetermined significance | GCST90624745 | 0.38 |
| 6934 | Liver fat | GCST90029073 | 0.38 |
| 6935 | IDP dMRI TBSS L2 Genu of corpus callosum | GCST90004125 | 0.38 |
| 6936 | red cell diameter width (RDW, mean, inv-norm transformed) | GCST90476361 | 0.38 |
| 6937 | SPRY2 levels | GCST90470738 | 0.38 |
| 6938 | SH3GLB2 levels | GCST90470621 | 0.38 |
| 6939 | MRC1 levels | GCST90469939 | 0.38 |
| 6940 | Neutrophil count | GCST90002351 | 0.38 |
| 6941 | monocyte (absolute count, maximum, inv-norm transformed) | GCST90475499 | 0.38 |
| 6942 | Total lipids in medium VLDL | GCST90499004 | 0.38 |
| 6943 | ORM1 levels | GCST90470129 | 0.38 |
| 6944 | Carotid artery plaque burden | GCST90503076 | 0.38 |
| 6945 | Other disorders of breast | FING00001018 | 0.38 |
| 6946 | Cholesteryl ester levels in large VLDL | GCST90092870 | 0.38 |
| 6947 | IL12A_IL12B/LAG3 ratio | GCST90315147 | 0.38 |
| 6948 | CLEC1B/MPIG6B ratio | GCST90314098 | 0.38 |
| 6949 | CLEC3B levels | GCST90468770 | 0.38 |
| 6950 | IL18BP levels | GCST90469564 | 0.38 |
| 6951 | Severe autoimmune type 2 diabetes | GCST90026412 | 0.38 |
| 6952 | Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary Administration | UKBB00000837 | 0.38 |
| 6953 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320944 | 0.38 |
| 6954 | Free cholesterol levels in medium HDL | GCST90132679 | 0.38 |
| 6955 | DTI TBSS MD Posterior corona radiata L | GCST90384599 | 0.38 |
| 6956 | Total lipids in large LDL (UKB data field 23531) | GCST90269628 | 0.38 |
| 6957 | SPP1 levels | GCST90470733 | 0.38 |
| 6958 | NT5E levels | GCST90470093 | 0.37 |
| 6959 | Cholesteryl esters in small LDL (UKB data field 23548) | GCST90269645 | 0.37 |
| 6960 | PPME1/PSMD9 ratio | GCST90315705 | 0.37 |
| 6961 | CA13 levels | GCST90468508 | 0.37 |
| 6962 | ENO2/FXYD5 ratio | GCST90314659 | 0.37 |
| 6963 | Social trust (aggregated) | GCST90319315 | 0.37 |
| 6964 | ADGRE5/GAS6 ratio | GCST90313179 | 0.37 |
| 6965 | F11R/PLXNA4 ratio | GCST90314724 | 0.37 |
| 6966 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T472 | ECGA000472 | 0.37 |
| 6967 | creatinine (maximum, inv-norm transformed) | GCST90475226 | 0.37 |
| 6968 | Bone density T-score | GCST90278620 | 0.37 |
| 6969 | Cholesterol levels in small LDL | GCST90092956 | 0.37 |
| 6970 | PRDX5 levels | GCST90470318 | 0.37 |
| 6971 | Ever suffered mental distress preventing usual activities | Mental distress | UKBB00000223 | 0.37 |
| 6972 | CEP43/USP8 ratio | GCST90314022 | 0.37 |
| 6973 | Descending aorta strain | GCST90267389 | 0.37 |
| 6974 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97) | GCST90320916 | 0.37 |
| 6975 | Triglycerides to total lipids in very large HDL percentage (UKB data field 23633) | GCST90269730 | 0.37 |
| 6976 | Blood urea nitrogen (BUN, minimum, inv-norm transformed) | GCST90475168 | 0.37 |
| 6977 | AHSA1 levels | GCST90468262 | 0.37 |
| 6978 | F-sharp flavour liking (derived food-liking factor) | GCST90094837 | 0.37 |
| 6979 | MASP1 levels | GCST90469863 | 0.37 |
| 6980 | ACYP2 levels | GCST90240187 | 0.37 |
| 6981 | CDH3 levels | GCST90468674 | 0.36 |
| 6982 | EDAR/TXNDC5 ratio | GCST90314593 | 0.36 |
| 6983 | CLEC1A/CLEC7A ratio | GCST90314083 | 0.36 |
| 6984 | Cholesterol esters in very large HDL | GCST90500344 | 0.36 |
| 6985 | Cholelithiasis | Disorders of gallbladder, biliary tract and pancreas | UKBB00000132 | 0.36 |
| 6986 | Degree of unsaturation | GCST90500162 | 0.36 |
| 6987 | Phospholipids in small VLDL (UKB data field 23511) | GCST90269608 | 0.36 |
| 6988 | CA2/PSMG3 ratio | GCST90313581 | 0.36 |
| 6989 | Cholesteryl Esters to Total Lipids in Large VLDL percentage | GCST90498162 | 0.36 |
| 6990 | AXIN1/GOPC ratio | GCST90313407 | 0.36 |
| 6991 | Frontotemporal dementia | FING00000560 | 0.36 |
| 6992 | Omega-6 fatty acids to omega-3 fatty acids ratio | GCST90499194 | 0.36 |
| 6993 | IDP dMRI TBSS FA Uncinate fasciculus R | GCST90003921 | 0.36 |
| 6994 | Platelet crit (UKB data field 30090) | GCST90468096 | 0.36 |
| 6995 | Platelet count during third trimester of pregnancy | GCST90302226 | 0.36 |
| 6996 | FGF19 levels | GCST90469220 | 0.36 |
| 6997 | Cholesteryl ester levels in VLDL | GCST90092997 | 0.36 |
| 6998 | GLRX5 levels | GCST90469361 | 0.36 |
| 6999 | ERBIN levels | GCST90469142 | 0.36 |
| 7000 | LAMB1 levels | GCST90469732 | 0.36 |